ALPS Advisors’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Sell |
29,430
-10,460
| -26% | -$119K | ﹤0.01% | 897 |
|
|
2025
Q1 | $265K | Sell |
39,890
-2,940
| -7% | -$19.6K | ﹤0.01% | 933 |
|
|
2024
Q4 | $472K | Buy |
+42,830
| New | +$472K | ﹤0.01% | 621 |
|
|
2023
Q4 | – | Sell |
-32,647
| Closed | -$129K | – | 1011 |
|
|
2023
Q3 | $129K | Buy |
32,647
+165
| +0.5% | +$650 | ﹤0.01% | 966 |
|
|
2023
Q2 | $345K | Buy |
32,482
+3,397
| +12% | +$36.1K | ﹤0.01% | 741 |
|
|
2023
Q1 | $242K | Buy |
29,085
+2,336
| +9% | +$19.5K | ﹤0.01% | 964 |
|
|
2022
Q4 | $247K | Buy |
26,749
+5,234
| +24% | +$48.3K | ﹤0.01% | 968 |
|
|
2022
Q3 | $276K | Sell |
21,515
-1,730
| -7% | -$22.2K | ﹤0.01% | 930 |
|
|
2022
Q2 | $307K | Sell |
23,245
-15,148
| -39% | -$200K | ﹤0.01% | 786 |
|
|
2022
Q1 | $808K | Sell |
38,393
-4,178
| -10% | -$87.9K | 0.01% | 332 |
|
|
2021
Q4 | $1.02M | Sell |
42,571
-2,463
| -5% | -$59.1K | 0.01% | 354 |
|
|
2021
Q3 | $1.15M | Sell |
45,034
-3,317
| -7% | -$84.4K | 0.01% | 376 |
|
|
2021
Q2 | $1.63M | Buy |
+48,351
| New | +$1.63M | 0.01% | 353 |
|